MedTrace Logo

Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response

NCT02540759 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2016-03-11

No results posted yet for this study

Summary

The effect of various doses of Buglossoides oil on the accrual of eicosapentaenoic acid (EPA) in blood and circulating cells will be investigated.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Buglossoides oil

DIETARY_SUPPLEMENT

High Oleic Sunflower Oil

Sponsors & Collaborators

  • Réseau de Santé Vitalité Health Network

    lead OTHER

Principal Investigators

  • Marc Surette, PhD · Université de Moncton, Moncton, NB, Canada

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02540759 on ClinicalTrials.gov